Daiichi Sankyo is an innovative global healthcare company contributing to the sustainable development of society that discovers, develops, and delivers new standards of care to enrich the quality of life around the world. With a legacy of innovation since 1899, Daiichi Sankyo leverages its world-class science and technology to create new modalities and innovative medicines for people with cancer, cardiovascular, and other diseases with high unmet medical need.
At Daiichi Sankyo, we believe that true progress comes from listening to patients, understanding their perspectives, and ensuring that every advancement translates into real, significant benefits. Especially so in oncology, as a constantly evolving field that is driven by innovation and new scientific discoveries. We are deeply committed to advancing research and developing new treatment options to bring our therapies to any patient who can benefit.
We believe we are stronger together, uniting colleagues from diverse backgrounds and working as a trusted partner alongside healthcare providers, patient representatives, industry leaders, and more. Through openness and collaboration, we strive to bring new therapies to people living with cancer, because we know that only together, we can improve standards of care and create better futures through medicine.
IE/DS8/04/26/0005 Date of preparation: April 2026
